Related Experiment Video
Updated: Mar 2, 2026
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Crohn's Disease and Ulcerative Colitis Show Unique Cytokine Profiles
Zoltan H Nemeth1, Dorian A Bogdanovski1, Patricia Barratt-Stopper1
1Department of Surgery, Morristown Medical Center.
Insights
This study reveals distinct cytokine profiles in inflammatory bowel diseases (IBD). Crohn's disease (CD) shows Th17 responses, while ulcerative colitis (UC) exhibits Th2 patterns, offering insights into IBD pathophysiology.
Area of Science:
- Immunology
- Gastroenterology
- Molecular Biology
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), involves complex cytokine networks.
- CD is typically associated with T-helper type 1 (Th1) responses, while UC shows Th2 patterns.
- Recent findings highlight the infiltration of Th17 cells in inflamed intestinal regions of both CD and UC patients.
Purpose of the Study:
- To investigate and compare the distinct cytokine profiles in CD and UC.
- To focus on Th2 and Th17-related mediators in the context of IBD.
- To elucidate the role of specific cytokines in the pathophysiology of CD and UC.
Main Methods:
- Real-time polymerase chain reaction (PCR) was employed to quantify cytokine transcript levels.
- Mucosal specimens from inflamed and non-inflamed regions of CD patients (n=35), UC patients (n=20), and controls (n=54) were analyzed.
- Comparative analysis of cytokine expression patterns between disease groups and controls was performed.
Main Results:
- Elevated levels of IL-12 (p40), IL-18, IL-21, and IL-27 were observed in both CD and UC compared to controls.
- CD samples showed significant mRNA expression of IL-17, IL-23, and IL-32, suggesting a Th17 response.
- UC samples exhibited significantly increased mRNA levels of IL-5, IL-13, IL-15, and IL-33 compared to both CD and controls, indicating a Th2-dominant pattern.
Conclusions:
- Distinct cytokine network patterns in CD and UC contribute to their unique pathophysiology.
- Understanding these differential cytokine expressions is crucial for targeted IBD therapies.
- Pharmacological modulation of these cytokines may lead to more effective and personalized treatment strategies for IBD.
Introduction:
Networks of cytokines have been implicated in both forms of inflammatory bowel disease (IBD): Crohn's disease (CD) and ulcerative colitis (UC). While CD has associated with T-helper type 1 (Th1) immune responses, UC shows Th2 patterns. Recent studies reported that the inflamed intestinal regions in both CD and UC are significantly infiltrated with a newly described set of T helper, the Th17 cells. These cells have unique cytokine responses. These findings prompted us to further explore the cytokine profiles of CD and UC with a special focus on the Th2 and Th17 related mediators.
Methods:
Cytokine transcripts were compared using real-time polymerase chain reaction (PCR) in both inflamed and non-inflamed mucosal specimens from patients with active CD (n=35) or UC (n=20) and without CD or UC (Control, n=54).
Results:
In both CD and UC, interleukin (IL)-12 (p40), IL-18, IL-21 and IL-27 transcript levels were higher than in Control. The highest levels of cytokines were found in the diseased areas of CD and UC with only one exception; IL-12 (p40) in CD was more up-regulated in the non-diseased areas compared to diseased CD and Control specimens. CD samples but not UC specimens showed significant IL-17, IL-23, and IL-32 mRNA expression indicating a trend toward Th17 responses. In UC, however, IL-5, IL-13, IL-15 and IL-33 mRNA levels were significantly increased when compared to both CD and Control.
Conclusions:
The unique patterns of cytokine networks can help us to better understand the differential expression of their characteristic pathophysiology. In addition, the pharmacological regulation of these small molecules may hold promise to more effective and personalized therapies.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids